Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xaj1
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OZ Management | 70M | $118M | 75% | Jun 2026 |
|
| Camden Asset Management | 61M | $102M | 100% | Jun 2026 |
|
| Franklin Resources | 59M | $99M | 0% | Jun 2026 |
|
| Wolverine Asset Management | 51M | $85M | 797% | Jun 2026 |
|
| Ubs Global Asset Management Americas | 39M | $65M | 100% | Jun 2026 |
|
| Sunrise Partners Limited Partnership | 33M | $56M | 100% | Jun 2026 |
|
| Invesco | 29M | $49M | 0% | Jun 2026 |
|
| Citadel Advisors | 29M | $49M | 100% | Jun 2026 |
|
| Susquehanna Advisors Group | 18M | $294k | 133% | Jun 2026 |
|
| Alberta Investment Management Corporation | 15M | $25M | 50% | Jun 2026 |
|
| Aristeia Capital | 15M | $25M | 100% | Jun 2026 |
|
| BlackRock | 12M | $20M | -50% | Jun 2026 |
|
| Jpmorgan Chase & Co | 11M | $18M | 100% | Jun 2026 |
|
| Ameriprise Financial | 10M | $17M | 67% | Jun 2026 |
|
| Bank of America Corporation | 9.0M | $15M | 154% | Jun 2026 |
|
| Calamos Advisors | 8.1M | $14M | 0% | Jun 2026 |
|
| Nuveen | 8.0M | $14M | -61% | Jun 2026 |
|
| Advent Capital Management | 7.5M | $13M | 100% | Jun 2026 |
|
| State Street Corporation | 7.2M | $12M | 100% | Mar 2026 |
|
| CSS | 7.2M | $12M | -29% | Jun 2026 |
|
| FMR | 6.6M | $11M | -1% | Jun 2026 |
|
| Goldman Sachs Group | 6.3M | $11M | 130% | Jun 2026 |
|
| Gabelli Funds | 6.1M | $10M | 0% | Jun 2026 |
|
| Nicholas Investments Partners | 6.0M | $10M | 0% | Jun 2026 |
|
| Wellington Management Company | 5.8M | $9.8M | -29% | Jun 2026 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 5.0M | $8.4M | -50% | Jun 2026 |
|
| SSI Investment Management | 4.1M | $7.0M | 0% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $6.7M | 33% | Jun 2026 |
|
| Leucadia National Corporation | 3.1M | $5.2M | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.7M | $2.8M | 0% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.6M | $2.7M | 12% | Jun 2026 |
|
| 683 Capital Management | 1.0M | $1.7M | 0% | Jun 2026 |
|
| Lazard Asset Management | 843k | $14k | 0% | Jun 2026 |
|
| Toronto-Dominion Bank | 627k | $1.1M | 100% | Jun 2026 |
|
| Millennium Management | 500k | $842k | 0% | Jun 2026 |
|
| Kohlberg Kravis Roberts & Co | 385k | $649k | 100% | Jun 2026 |
|
| Ares Systematic Credit | 300k | $505k | 0% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 298k | $501k | 0% | Jun 2026 |
|
| Wellesley Investment Advisors | 275k | $463M | 120% | Jun 2026 |
|
| Diadema Partners | 250k | $19M | 0% | Jun 2026 |
|
| Central Pacific Bank - Trust Division | 236k | $397k | 100% | Jun 2026 |
|
| Man Group | 225k | $379k | 0% | Jun 2026 |
|
| Bank of New York Mellon | 200k | $337k | 0% | Jun 2026 |
|
| Persistent Asset Partners | 60k | $101k | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 30k | $5.0M | 0% | Jun 2026 |
|
| Wells Fargo & Company | 27k | $46k | -96% | Jun 2026 |
|
| Oddo Bhf Asset Management Sas | 227.00 | $384k | 100% | Jun 2026 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Mar 2026 | 133M | $225M |
| D. E. Shaw & Co | Mar 2026 | 63M | $107M |
| Jump Financial | Mar 2026 | 18M | $31M |
| Jane Street | Mar 2026 | 700k | $1.2M |